The novel coronavirus disease 2019 (COVID‐19) has been reported to affect the
gastrointestinal system with a variety of symptoms, including bleeding. The prevalence of …

COVID-19 infection is an ongoing catastrophic global pandemic with significant morbidity
and mortality that affects most of the world population. Respiratory manifestations …

Gastrointestinal (GI) symptoms are highly prevalent in coronavirus disease 2019 (COVID-
19) ranging from 17.6% to 53%. 1–4 The proposed mechanism for GI symptoms involves …

Background Corona virus disease 2019 (COVID‐19) patients are at increased risk for
thromboembolic events. It is unclear whether the risk for gastrointestinal (GI) bleeding is also …

Background The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and
a potential benefit of anticoagulation therapy has been documented for prevention of …

Objectives: To evaluate excess deaths of gastrointestinal, liver, and pancreatic diseases in
the United States during the COVID-19 pandemic. Methods: We retrieved weekly death …

Background Understanding risk factors for short-and long-term COVID-19 outcomes have
implications for current guidelines and practice. We study whether early identified risk factors …

SARS-COV 2 recently caused a global pandemic, with the first case being reported in
Romania in February 2020. Important restrictive measures were imposed, so that the …

The incidence of COVID-19 gastrointestinal manifestations has been reported to range from
3% to 61%. There are limited data on the incidence rates and risk factors associated with …

Gastrointestinal and Hepatobiliary Symptoms and Disorders with Long (Chronic) COVID Infection
- Gastroenterology Clinics Skip to Main Content Skip to Main Menu Advertisement …